InfraScan

Name

InfraScan

Legal name

InfraScan, Inc.

Website

https://infrascanner.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Devices - Portable Brain Scanners

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

Keywords

• Portable brain scanner
• Intracranial hematoma detection
• Near-infrared spectroscopy
• Traumatic brain injury triage
• Medical device imaging

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales: Sale of Infrascanner portable brain scanning devices (Models 2000 and 2500) to healthcare providers, military, and sports medicine organizations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

InfraScan develops, manufactures, and distributes the Infrascanner line of portable, handheld brain scanners (Models 2000 and 2500) that use Near-Infrared (NIR) spectroscopy to non-invasively screen head trauma patients for intracranial hematomas, enabling rapid triage and CT/neurosurgical referral. The devices are FDA-cleared and CE-marked and are sold to emergency rooms, intensive care units, military field hospitals, sports medicine programs, and ambulance services.

Product overview

InfraScan is a medical device company that offers two portable brain scanner products based on Near-Infrared (NIR) technology. The Infrascanner 2500 is the newer model serving as the primary portable screening device for detecting intracranial bleeding, while the Infrascanner 2000 is a ruggedized, lightweight handheld variant designed for military and field use. Both products use NIR spectroscopy to compare light absorption patterns between left and right sides of the brain to identify potential hematomas, enabling rapid triage and referral for CT scanning. The devices target emergency rooms, intensive care units, military field hospitals, sports medicine, and ambulance services.

Differentiator

Problem solved

Functional benefit

Products and services

• Infrascanner 2500 A portable screening device using Near-Infrared (NIR) technology to non-invasively screen head trauma patients for intracranial bleeding, identifying those who would most benefit from immediate referral to a CT scan and neurosurgical intervention. Targeted at emergency rooms, ICUs, military field hospitals, sports medicine, and ambulance services.
• Infrascanner 2000 A light-weight, handheld brain scanner providing a simple positive/negative graphic report for detection of traumatic supratentorial hematomas greater than 3.5 mL in volume and less than 2.5 cm from the brain surface. Ruggedized for durability in remote locations and on the battlefield, and operable via rechargeable NiMH battery pack or four disposable AA batteries. Targeted at military field use and remote TBI triage.

Quantifiable outcome

• 94% sensitivity and 96% specificity for intracranial bleed detection (Duke University study, 500 patients)
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• University of Pennsylvania (Dr. Britton Chance)coreStrategic or Co-development PartnerDr. Britton Chance from University of Pennsylvania co-invented the NIR system for brain hematoma detection and tested it successfully in 305 patients at Baylor College of Medicine. This foundational research partnership developed the core technology.
• Baylor College of Medicine (Dr. Claudia Robertson)coreStrategic or Co-development PartnerDr. Claudia Robertson co-invented the NIR system for brain hematoma detection and conducted successful clinical testing. The initial clinical validation was conducted at Baylor College of Medicine with 305 patients.
• Duke University Global Neurosurgery and NeurologycoreStrategic or Co-development PartnerConducted the largest independent U.S.-based Infrascanner study to date with 500 TBI patients including 104 with intracranial bleeds, demonstrating 94% sensitivity and 96% specificity.
• Penn State Milton S. Hershey Medical CenterminorStrategic or Co-development PartnerTrauma and ER teams led by Dr. Joshua Hazelton presented data at SAEM demonstrating Infrascanner achieved 95% sensitivity and 93% specificity in comparison to CT for early detection of brain hemorrhage.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Masimo: Masimo is a leading patient monitoring company whose cerebral oximetry and brain-monitoring products are sold into the same hospitals and emergency departments InfraScan targets, with much broader commercial reach.
• Integra LifeSciences: Integra LifeSciences is a broad neurosurgery and neurocritical care device company selling into trauma centers and neurosurgery departments, providing overlapping customer relationships and procedural adjacency to InfraScan's TBI triage use case.
• Stryker (Neurovascular & Emergency Care): Stryker's neurovascular portfolio and emergency medical equipment serve the same hospital and emergency medicine customers as InfraScan, with substantially larger commercial scale and broader TBI workflow solutions.

Emerging players

• Penumbra: Penumbra develops neurovascular devices including stroke treatment and more recently computer-assisted vacuum thrombectomy, with overlapping clinical adjacency in ischemic and hemorrhagic stroke workflows.
• Nonin Medical: Nonin Medical makes cerebral oximetry and pulse oximetry devices used in neurological monitoring and emergency response, providing adjacent brain-physiology diagnostic capability competing for similar clinical workflow slots.
• Ceribell: Ceribell makes portable, rapid-response EEG brain monitoring for emergency and ICU settings, addressing acute neurological assessment and overlapping with InfraScan's hospital and emergency department customer base.

Direct peers

• NovaSignal: NovaSignal develops portable transcranial Doppler ultrasound for automated cerebral blood flow assessment, targeting stroke and TBI triage use cases that overlap directly with InfraScan's prehospital/intracranial assessment positioning.
• BrainScope: BrainScope develops FDA-cleared, handheld EEG-based devices for objective TBI assessment in head injury, making it the closest direct competitor to InfraScan's portable brain hematoma detection in the emergency and military triage market.
• Natus Medical: Natus Medical manufactures neurological diagnostic and monitoring devices including EEG and neurocritical care products, overlapping with InfraScan's neurodiagnostic focus in hospital and ICU channels.
• Compumedics: Compumedics manufactures EEG and neurological diagnostic equipment used in clinical and research settings, with overlapping customer base in neurology and trauma centers where InfraScan is sold.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/infrascanner-1234560483222287
• LinkedInlinkedin.com/company/infrascan-inc-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InfraScan